These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30117736)

  • 41. Targeted nanoparticles assembled via complexation of boronic-acid-containing targeting moieties to diol-containing polymers.
    Han H; Davis ME
    Bioconjug Chem; 2013 Apr; 24(4):669-77. PubMed ID: 23461746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tailored Synthesis of PEGylated Bismuth Nanoparticles for X-ray Computed Tomography and Photothermal Therapy: One-Pot, Targeted Pyrolysis, and Self-Promotion.
    Xu W; Cui P; Happonen E; Leppänen J; Liu L; Rantanen J; Majda D; Saukko A; Thapa R; Nissinen T; Tynkkynen T; Töyräs J; Fan L; Liu W; Lehto VP
    ACS Appl Mater Interfaces; 2020 Oct; 12(42):47233-47244. PubMed ID: 32970405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of oil-in-water nanoemulsion polyethylene glycol surface density on intracellular stability, pharmacokinetics, and biodistribution in tumor bearing mice.
    Hak S; Garaiova Z; Olsen LT; Nilsen AM; de Lange Davies C
    Pharm Res; 2015 Apr; 32(4):1475-85. PubMed ID: 25348468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced uptake in 2D- and 3D- lung cancer cell models of redox responsive PEGylated nanoparticles with sensitivity to reducing extra- and intracellular environments.
    Conte C; Mastrotto F; Taresco V; Tchoryk A; Quaglia F; Stolnik S; Alexander C
    J Control Release; 2018 May; 277():126-141. PubMed ID: 29534890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of Modular PEG Incorporation Strategies for Stabilization of Peptide-siRNA Nanocomplexes.
    Lo JH; Kwon EJ; Zhang AQ; Singhal P; Bhatia SN
    Bioconjug Chem; 2016 Oct; 27(10):2323-2331. PubMed ID: 27583545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overcoming the polyethylene glycol dilemma via pathological environment-sensitive change of the surface property of nanoparticles for cellular entry.
    Hama S; Itakura S; Nakai M; Nakayama K; Morimoto S; Suzuki S; Kogure K
    J Control Release; 2015 May; 206():67-74. PubMed ID: 25770398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent advances in PEG-PLA block copolymer nanoparticles.
    Xiao RZ; Zeng ZW; Zhou GL; Wang JJ; Li FZ; Wang AM
    Int J Nanomedicine; 2010 Nov; 5():1057-65. PubMed ID: 21170353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-circulating Janus nanoparticles made by electrohydrodynamic co-jetting for systemic drug delivery applications.
    Rahmani S; Villa CH; Dishman AF; Grabowski ME; Pan DC; Durmaz H; Misra AC; Colón-Meléndez L; Solomon MJ; Muzykantov VR; Lahann J
    J Drug Target; 2015; 23(7-8):750-8. PubMed ID: 26453170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG.
    McSweeney MD; Price LSL; Wessler T; Ciociola EC; Herity LB; Piscitelli JA; DeWalle AC; Harris TN; Chan AKP; Saw RS; Hu P; Jennette JC; Forest MG; Cao Y; Montgomery SA; Zamboni WC; Lai SK
    J Control Release; 2019 Oct; 311-312():138-146. PubMed ID: 31454530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
    Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E
    J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of anti-PEG antibodies on PEGylated nanoparticles fate in vivo.
    Park K
    J Control Release; 2018 Oct; 287():257. PubMed ID: 30243349
    [No Abstract]   [Full Text] [Related]  

  • 53. Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly(lactic acid)-poly(ethylene glycol) nanoparticles through caveolae-mediated endocytosis.
    Liu C; Yu W; Chen Z; Zhang J; Zhang N
    J Control Release; 2011 Apr; 151(2):162-75. PubMed ID: 21376765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanoparticle Surface Engineering with Heparosan Polysaccharide Reduces Serum Protein Adsorption and Enhances Cellular Uptake.
    Yang W; Wang L; Fang M; Sheth V; Zhang Y; Holden AM; Donahue ND; Green DE; Frickenstein AN; Mettenbrink EM; Schwemley TA; Francek ER; Haddad M; Hossen MN; Mukherjee S; Wu S; DeAngelis PL; Wilhelm S
    Nano Lett; 2022 Mar; 22(5):2103-2111. PubMed ID: 35166110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.
    Lu W; Wan J; She Z; Jiang X
    J Control Release; 2007 Mar; 118(1):38-53. PubMed ID: 17240471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coating Metal Nanoparticle Surfaces with Small Organic Molecules Can Reduce Nonspecific Cell Uptake.
    Van Haute D; Liu AT; Berlin JM
    ACS Nano; 2018 Jan; 12(1):117-127. PubMed ID: 29261281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles.
    Elsewedy HS; Dhubiab BEA; Mahdy MA; Elnahas HM
    Drug Deliv; 2020 Dec; 27(1):1134-1146. PubMed ID: 32729331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo.
    Allard-Vannier E; Cohen-Jonathan S; Gautier J; Hervé-Aubert K; Munnier E; Soucé M; Legras P; Passirani C; Chourpa I
    Eur J Pharm Biopharm; 2012 Aug; 81(3):498-505. PubMed ID: 22510695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan.
    Sheng Y; Liu C; Yuan Y; Tao X; Yang F; Shan X; Zhou H; Xu F
    Biomaterials; 2009 Apr; 30(12):2340-8. PubMed ID: 19150737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.